New Quality Forces New Growth Unleashed

BIOLIGN Conference Guangzhou 2025

May 14-15 | Guangzhou, China

One of the most expected pharmaceutical
industry events in the Greater Bay Area

BIOLIGN CONFERENCE

The BIOLIGN Conference Guangzhou 2025 aims to provide a high-level platform for government agencies, local/multinational pharmaceutical companies, Biotech, CRO/CDMO/CMO, investment institutions, research institutes and universities, parks, intelligentization, automation, digitalization, detection/quality analysis, gene sequencing and multi-omics research, organoid/ animal models/drug sensitivity testing, instruments/equipment/reagents, cell culture/virus vectors/consumables, single-use technology, purification/separation, law firms/consulting firms and other relevant institutions to exchange ideas, refine consensus, gain insights into the frontier trends and technological innovations in the pharmaceutical industry, and jointly explore the path of collaborative innovation in the pharmaceutical biotechnology industry.

Click here for post-event highlights and live coverage of BIOLIGN Thousand-people Assembly in East China！

Download Post-event Report of East China Conference

BIOLIGN 2025@Guangzhou

3500+

ATTENDEES

200+

SPEAKERS

1000+

B2B MATCHMAKING

100+

SPONSORS

New Quality Forces New Growth Unleashed

Part of Previous Speakers

Dawei Ma

Academician
The Chinese Academy of
Sciences

Zhigang Tian

Academician
The Chinese Academy
of Engineering

Hongzhou Lu

AAM Fellow
Dean of The Third People's
Hospital of Shenzhen

Xumu Zhang

RAE Foreign Member

Jinhui Li

General Manager of
Hospital's Emergency BU
Pfizer China

Kaisheng Huang

CQO
RemeGen Co., Ltd.

Judy Deng

Head of Market Access and
Key Account Department
Novartis China

Yutian Wang

Academician
Royal Society of Canada
>

Jens Ewert

Life Sciences &
Health Care Leader
Deloitte China

Li Mao

VP, GM of Research and
Development&CMO
SciClone

Mingxiu Hu

SVP
Akeso

Li Chen

Founder and
CEO,CSO
Hua Medicine

Shaojing Hu

Chairman&CEO
3H Pharmaceuticals

Zhuli Wu

Senior Vice President of
Global R&D Center,
Chief Medical Officer (Oncology),
Fosun Pharma

Dongzhou Liu

CSO & President of
Global Development
Huadong Medicine

Cheng Zhang

SVP & CSO
Gmax Biopharm LLC

Aimin Hui

General Manager
SharpSight Biopharma
Consulting

Wenzhi Tian

Chairman and GM
ImmuneOnco

Linna Wang

CMO at Chia Tai
Innovation R&D Center,
China Biopharma

Li Zhou

CSO
Juventas Cell
Therapy

Gang Qin

CEO/Founder/Chairman
GeneQuantum
Healthcare

Ruhong Jiang

CEO
ASC Therapeutics

Gong Chen

Founder
NeuExcell
NeuExcell
Therapeutics

Fubing Li

Co-Founder/CSO
Constimulus

Wenji Dong

Founder&CEO
Genmedicn Biopharma

Jiaqiang Cai

Co-founder&CSO&CSO
MediLink Therapeutics

Wenjun Zhang

CEO
ExcelMab

Penghui Zhou

创始人
Founder
Fanen Biotechnology

Dan Liu

Senior Partner
CDH Investments

Bo Liu

Managing Director
CDIB Capital

Liang Xiao

Co-Founder & COO
MediLink
Therapeutics

Hong Wen

Partner
Shanghai Biomedical
Industry Equity Investment Fund

Jianhua Su

SVP &
General Manager
EpimAb

Jiong Lan

Founder&CEO
GenFleet Therapeutics

Minmin SUN

Founder & Chairman
&CEO
Immunofoco

Lei Fang

VP
Lepu Biopharma

Zhong Liu

VP
Lunan Pharmaceutical Group

Hugh Davis

COO&President of
U.S. Branch
Biosion

Tony Guo

VP and Global Head of
Statistics and Data Sceince
BeiGene

Qiusong Tang

Head, Roche China
Accelartor
Roche

Ling Yang

VP
CTTQ PHARMA

Xiaoyan Kang

Executive VPof Clinical
Development Center
& CMO (Oncology)
Qilu Pharmaceutical

James Yan

Chief Operating Officer, R&D
Zai Lab Limited

Wei Long

Executive VP
of Preclinical R&D
JACOBIO

Wei Chen

Vice President of R&D
Gan & Lee Pharmaceuticals

Zhenping Wu

SVP
HUTCHMED

Jin Han

General Manager
Tasly Pharmaceutical

Hena Shi

VP & GM of Oncology Division
Betta Pharmaceuticals

In Alphabetical Order
Job Titles Align with the Newest Information

Part of Collaborative Partners

Part of Media Partners

Industry Insights – Empowering Innovations

Selected Product & Technical White Papers

Selected Research Report from Consultancies

Exclusive Interviews of Executives and Experts

Spectacle of Previous Conferences

Formats of BIOLIGN 2025

To Be Sponsors

Efficient 1-on-1 business matchmaking on-site, accurately reaching potential target customers Opportunities for deep involvement in the main forum, sub-forums, and roundtables, fully showcasing industry leadership Exclusive opportunities for on-site tea breaks, badge sponsorship, etc., to enhance brand visibility Unique customized programs that align with promotional goals, enjoying high exposure online and offline before,

To Be Exhibitor

Efficient 1-on-1 business matchmaking on-site, accurately reaching potential target customers Limited exhibition slots in specific fields, gathering industry attention and directing potential clients to exclusive exhibition areas Get a conference VIP pass for full access to the keynote session, sub-forums, and roundtables, to grasp the latest industry trends

To Be Attendee

Get a conference VIP pass for full access to keynote session, sub-forums, and 8 roundtables, to grasp the latest industry trends. Opportunity to interact and exchange opinions with decision-makers and experts from leading pharmaceutical and biotech companies on-site

To Be Speaker

Exclusive speaking opportunity to showcase solutions and project progress, and share professional knowledge, experience, and insights. Opportunity to interact and exchange perspectives with decision-makers and experts from leading pharmaceutical and biotech companies on-site. Speakers’ names and profiles will be included in the conference brochure

BIOLIGN

Dedicating to providing world-class platform for high-quality communication and collaboration，BIOLIGN is the leading brand of commercial events and community in the pharmaceutical industry, which covers the areas such as biopharmaceuticals, small molecule innovation drugs, synthetic biology, precision medicine. BIOLIGN conference will address the latest industry hotspots and trends, emphasize nextgeneration innovative therapies and disruptive new technologies, and bring together industry leaders and elites to discuss openly about future strategies that can inspire innovation, upgrades and transformation of pharmaceutical industry.

It consistently adheres to the 3C philosophy, namely Creativity, Connection and Changes, and is committed to promoting industry momentum and resource integration to maximize commercial value.

Register

Contact us

Phone： 0086-20-89305001

Email： lbz@epochsgroup.com

Website： biolign.lbzepochs.com

Customer service：

WeChat QR code：